Holen Sie sich die Stockscreener-App
477.73
2.50%
-12.27
Handel nachbörslich:
479.40
1.67
+0.35%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MSFT?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$490.00
Offen:
$476.32
24-Stunden-Volumen:
33.62M
Relative Volume:
1.54
Marktkapitalisierung:
$3.55T
Einnahmen:
$293.81B
Nettoeinkommen (Verlust:
$104.91B
KGV:
33.99
EPS:
14.0558
Netto-Cashflow:
$78.02B
1W Leistung:
-1.60%
1M Leistung:
-7.60%
6M Leistung:
+3.19%
1J Leistung:
+10.79%
1-Tages-Spanne:
$475.20
$484.24
1-Wochen-Bereich:
$475.20
$493.50
52-Wochen-Spanne:
$344.79
$555.45
Microsoft Corporation Stock (MSFT) Company Profile
Firmenname
Microsoft Corporation
Sektor
Branche
Telefon
425-882-8080
Adresse
ONE MICROSOFT WAY, REDMOND, WA
Vergleichen Sie MSFT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MSFT
Microsoft Corporation
|
477.73 | 3.64T | 293.81B | 104.91B | 78.02B | 14.06 |
|
ORCL
Oracle Corp
|
207.73 | 573.29B | 59.02B | 12.63B | -5.88B | 4.3198 |
|
PLTR
Palantir Technologies Inc
|
176.08 | 406.83B | 3.90B | 1.10B | 1.79B | 0.4275 |
|
CRWD
Crowdstrike Holdings Inc
|
524.17 | 129.63B | 4.34B | -298.19M | 1.04B | -1.1966 |
|
SNPS
Synopsys Inc
|
466.44 | 85.63B | 6.43B | 1.15B | 1.30B | 12.77 |
Microsoft Corporation Stock (MSFT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-11-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-10-30 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-10-27 | Hochstufung | Guggenheim | Neutral → Buy |
| 2025-10-22 | Bestätigt | Citigroup | Buy |
| 2025-10-17 | Bestätigt | Mizuho | Outperform |
| 2025-10-06 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-07-31 | Bestätigt | Barclays | Overweight |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Jefferies | Buy |
| 2025-07-31 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-31 | Bestätigt | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-22 | Bestätigt | Citigroup | Buy |
| 2025-07-16 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-07-16 | Bestätigt | Mizuho | Outperform |
| 2025-07-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-07-02 | Bestätigt | DA Davidson | Buy |
| 2025-06-25 | Bestätigt | Wedbush | Outperform |
| 2025-06-11 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-05-01 | Bestätigt | Barclays | Overweight |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | Mizuho | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | RBC Capital Mkts | Outperform |
| 2025-05-01 | Bestätigt | Raymond James | Outperform |
| 2025-05-01 | Bestätigt | Scotiabank | Sector Outperform |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-17 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-04-16 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-04-16 | Bestätigt | Morgan Stanley | Overweight |
| 2025-04-14 | Bestätigt | UBS | Buy |
| 2025-04-14 | Bestätigt | Wells Fargo | Overweight |
| 2025-03-20 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-03-13 | Hochstufung | DA Davidson | Neutral → Buy |
| 2025-01-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Piper Sandler | Overweight |
| 2024-10-31 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-10-10 | Bestätigt | Goldman | Buy |
| 2024-10-08 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-09-23 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-06-10 | Eingeleitet | New Street | Buy |
| 2024-06-07 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-04-12 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-04-11 | Bestätigt | Morgan Stanley | Overweight |
| 2024-03-21 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-01-18 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2023-12-13 | Eingeleitet | Truist | Buy |
| 2023-12-05 | Eingeleitet | China Renaissance | Buy |
| 2023-10-26 | Hochstufung | HSBC Securities | Hold → Buy |
| 2023-10-17 | Eingeleitet | Loop Capital | Buy |
| 2023-09-25 | Hochstufung | Guggenheim | Sell → Neutral |
| 2023-09-15 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-24 | Bestätigt | Goldman | Buy |
| 2023-07-24 | Bestätigt | Raymond James | Outperform |
| 2023-07-21 | Bestätigt | Goldman | Buy |
| 2023-07-19 | Bestätigt | Barclays | Overweight |
| 2023-07-19 | Bestätigt | BofA Securities | Buy |
| 2023-07-19 | Bestätigt | Mizuho | Buy |
| 2023-07-19 | Bestätigt | TD Cowen | Outperform |
| 2023-07-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-07-17 | Bestätigt | Mizuho | Buy |
| 2023-07-14 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-13 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-26 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-04-26 | Bestätigt | Goldman | Buy |
| 2023-04-26 | Bestätigt | Guggenheim | Sell |
| 2023-04-26 | Bestätigt | JP Morgan | Overweight |
| 2023-04-26 | Bestätigt | Jefferies | Buy |
| 2023-04-26 | Hochstufung | Macquarie | Neutral → Outperform |
| 2023-04-26 | Bestätigt | Mizuho | Buy |
| 2023-04-26 | Bestätigt | MoffettNathanson | Market Perform |
| 2023-04-26 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-26 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-26 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-26 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-26 | Bestätigt | Raymond James | Outperform |
| 2023-04-26 | Bestätigt | Rosenblatt | Buy |
| 2023-04-26 | Bestätigt | Stifel | Buy |
| 2023-04-26 | Bestätigt | TD Cowen | Outperform |
| 2023-04-26 | Bestätigt | UBS | Neutral |
| 2023-04-26 | Bestätigt | Wedbush | Outperform |
| 2023-04-26 | Bestätigt | Wells Fargo | Overweight |
| 2023-04-26 | Bestätigt | Wolfe Research | Outperform |
| 2023-04-24 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2023-04-21 | Bestätigt | BMO Capital Markets | Market Perform |
| 2023-04-20 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Deutsche Bank | Buy |
| 2023-01-25 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2023-01-05 | Eingeleitet | DA Davidson | Buy |
| 2023-01-04 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-02 | Eingeleitet | Macquarie | Neutral |
| 2022-10-14 | Bestätigt | Morgan Stanley | Overweight |
| 2022-09-30 | Fortgesetzt | Raymond James | Outperform |
| 2022-09-22 | Eingeleitet | MoffettNathanson | Hold |
| 2022-08-12 | Eingeleitet | Guggenheim | Neutral |
| 2022-07-27 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-07-27 | Bestätigt | Citigroup | Buy |
| 2022-07-27 | Bestätigt | Cowen | Outperform |
| 2022-07-27 | Bestätigt | Deutsche Bank | Buy |
| 2022-07-27 | Bestätigt | Stifel | Buy |
| 2022-07-27 | Bestätigt | Wedbush | Outperform |
| 2022-07-26 | Eingeleitet | Itau BBA | Outperform |
| 2022-07-19 | Bestätigt | Citigroup | Buy |
| 2022-06-29 | Eingeleitet | Redburn | Buy |
| 2022-04-27 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2022-04-27 | Bestätigt | Evercore ISI | In-line |
| 2022-04-27 | Bestätigt | Stifel | Buy |
| 2022-04-27 | Bestätigt | Wedbush | Outperform |
| 2022-04-27 | Bestätigt | Wolfe Research | Outperform |
| 2022-01-26 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-01-26 | Bestätigt | Citigroup | Buy |
| 2022-01-26 | Bestätigt | Morgan Stanley | Overweight |
| 2022-01-26 | Bestätigt | Oppenheimer | Outperform |
| 2022-01-12 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-22 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-11-22 | Eingeleitet | Wells Fargo | Overweight |
| 2021-11-16 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-11-02 | Eingeleitet | Deutsche Bank | Buy |
| 2021-10-27 | Bestätigt | Barclays | Overweight |
| 2021-10-27 | Bestätigt | BofA Securities | Buy |
| 2021-10-27 | Bestätigt | Cowen | Outperform |
| 2021-10-27 | Bestätigt | Credit Suisse | Outperform |
| 2021-10-27 | Bestätigt | Goldman | Buy |
| 2021-10-27 | Bestätigt | Mizuho | Buy |
| 2021-10-27 | Bestätigt | Morgan Stanley | Overweight |
| 2021-10-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-10-27 | Bestätigt | Stifel | Buy |
| 2021-09-17 | Fortgesetzt | Rosenblatt | Buy |
| 2021-09-14 | Bestätigt | Morgan Stanley | Overweight |
| 2021-08-20 | Bestätigt | Mizuho | Buy |
| 2021-07-28 | Bestätigt | Barclays | Overweight |
| 2021-07-28 | Bestätigt | Bernstein | Outperform |
| 2021-07-28 | Bestätigt | BofA Securities | Buy |
| 2021-07-28 | Bestätigt | Citigroup | Buy |
| 2021-07-28 | Bestätigt | Cowen | Outperform |
| 2021-07-28 | Bestätigt | Credit Suisse | Outperform |
| 2021-07-28 | Bestätigt | Griffin Securities | Buy |
| 2021-07-28 | Bestätigt | Mizuho | Buy |
| 2021-07-28 | Bestätigt | Morgan Stanley | Overweight |
| 2021-07-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-07-28 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-07-28 | Bestätigt | Rosenblatt | Buy |
| 2021-07-28 | Bestätigt | Stifel | Buy |
| 2021-07-28 | Bestätigt | Wolfe Research | Outperform |
| 2021-07-22 | Bestätigt | BofA Securities | Buy |
| 2021-07-22 | Bestätigt | Citigroup | Buy |
| 2021-07-22 | Bestätigt | Cowen | Outperform |
| 2021-07-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2021-06-23 | Bestätigt | Wedbush | Outperform |
| 2021-05-13 | Eingeleitet | Rosenblatt | Buy |
| 2021-04-23 | Eingeleitet | Wolfe Research | Outperform |
| 2021-04-12 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-04-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-16 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-03 | Fortgesetzt | Citigroup | Buy |
| 2021-01-26 | Fortgesetzt | Raymond James | Strong Buy |
| 2021-01-22 | Eingeleitet | Goldman | Buy |
| 2020-12-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-12-16 | Fortgesetzt | BofA Securities | Buy |
| 2020-11-24 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-11-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-10-14 | Fortgesetzt | UBS | Buy |
| 2020-07-23 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-07-20 | Bestätigt | Stifel | Buy |
| 2020-07-15 | Bestätigt | BMO Capital Markets | Outperform |
| 2020-07-09 | Bestätigt | Wedbush | Outperform |
| 2020-06-24 | Bestätigt | Argus | Buy |
| 2020-06-02 | Bestätigt | Wells Fargo | Overweight |
| 2020-05-27 | Eingeleitet | Summit Insights | Buy |
| 2020-04-30 | Bestätigt | Griffin Securities | Buy |
| 2020-01-30 | Bestätigt | Oppenheimer | Outperform |
| 2020-01-30 | Bestätigt | Piper Sandler | Overweight |
| 2020-01-30 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-01-30 | Bestätigt | Raymond James | Strong Buy |
| 2020-01-30 | Bestätigt | Stifel | Buy |
| 2020-01-30 | Bestätigt | Wedbush | Outperform |
| 2020-01-30 | Bestätigt | Wells Fargo | Overweight |
Alle ansehen
Microsoft Corporation Aktie (MSFT) Neueste Nachrichten
Is Palantir's Deal With Nvidia a Game Changer? - The Motley Fool
Stock Movers: Salesforce, Snowflake, Microsoft - Bloomberg.com
Microsoft shares fall 2% after AI sales targets reportedly missed - Tech in Asia
AVASOFT Earns Microsoft Honors as Demand for AI-Driven Enterprise Solutions Surges - MyChesCo
Reports claimed that Microsoft lowered its sales quota for AI software, causing its stock price to drop nearly 3% at one point; Microsoft later denied the claim. - 富途牛牛
Microsoft Corporation (MSFT) Stock: Slides as Report Claims AI Sales Miss Growth Targets - CoinCentral
Tech Gains Limited Amid Microsoft AI FearsTech Roundup - MarketScreener
What’s New in Microsoft 365December 2025 - Seton Hall University
AWS AI IDE, AgentCore throw down gauntlets for Microsoft - TechTarget
Microsoft makes Copilot available to secure cloud customers - Nextgov/FCW
Microsoft Stock Slips On Report Customers Resisting AI Products - Investor's Business Daily
Microsoft Defender XDR portal hit by extended outage - SC Media
Microsoft lowers AI software sales quota as customers resist new products, The Information reports - WTVB
Report: Microsoft Cuts AI Software Sales Goals Amid Low Demand - tech.co
Microsoft (MSFT) pushes back on report of lowering AI sales goals after missing them in FY25 - Shacknews
Why Microsoft Fell Today, But Then Recovered - Yahoo Finance
Why Is Microsoft (MSFT) Stock Falling Today? - Yahoo Finance
Microsoft trims its AI business ambitions, hindered by demand - MarketScreener
Microsoft Stock Slides as AI Software Demand Fails to Meet Expectations - TECHi
Microsoft Stock Is Down 1.7%. Here’s Why. - Forbes
Microsoft-Backed OpenAI to Acquire AI Tool Developer Neptune - MarketScreener
Reports Say Microsoft (MSFT) Lowered AI Sales Quotas Due to Weak Demand - TipRanks
Microsoft stock falls 3% on AI quota‑cut news and lawsuit accusing it of ‘aiding’ Israel - Cryptopolitan
‘Microsoft workers refuse to be complicit in the genocide’ - The Real News Network
Microsoft Refutes Report It Lowered AI Software Sales Quotas - MarketScreener
Microsoft Slips on Report of Lower Demand for Some AI Tools - Bloomberg.com
Microsoft Refutes Report It Lowered AI Software Sales Quotas, CNBC Reports - MarketScreener
MICROSOFT CORP : Jefferies gives a Buy rating - MarketScreener
Microsoft drops AI sales targets in half after salespeople miss their quotas - Ars Technica
Windows 11 zero-day security vulnerability gets partial fix from Microsoft - How-To Geek
Microsoft Stock Falls on Report About Reduction Ambition for AI Sales - Barron's
Microsoft Slides as AI Product Sales Reportedly Fall Short of Growth Targets - Wall Street Pit
AI Daily: Microsoft said to lower AI software growth targets - TipRanks
Report: Microsoft AI Sales Miss, Company Denies Lowering Quotas - WinBuzzer
Microsoft slips on report of lower demand for some AI tools - The Mercury News
Microsoft Stock (MSFT) Bounces after Company Denies Report that It Cut Sales Quotas - TipRanks
Microsoft : More than 70% of the US could benefit from accessible technology - MarketScreener
Microsoft’s Strong Growth Potential and AI Leadership Drive Buy Rating - TipRanks
Microsoft Lowers AI Sales Quotas Amid Customer Resistance and Stock Dip - WebProNews
Microsoft Stock (MSFT) Opinions on AI Sales Forecast Reduction - Quiver Quantitative
Microsoft denies report of lowering targets for AI software sales growth - Reuters
Microsoft Stock Slips as "Hesitant" Clients Reportedly Force Cuts to AI Sales Goals - inkl
Stocks Waver on Weak Jobs Data; Microsoft Drags Tech Lower - Bloomberg.com
Microsoft erases some losses as it denies report it cut sales quotas tied to AI (MSFT:NASDAQ) - Seeking Alpha
Microsoft's reported sales struggles are a warning that huge AI spending might take a while to pay off - Business Insider Africa
Announcing the Microsoft Store Awards 2025 winners - Windows Blog
Microsoft shares slide on AI concerns - Proactive Investors
Nebius expands AI through billion-dollar deals with Microsoft and Meta - Techzine Global
Microsoft "mitigates" Windows LNK flaw exploited as zero-day - BleepingComputer
Microsoft May Be an AI Tech Giant, But It Is Also One of the Safest Stocks to Own Now, According to Wall Street - Barchart.com
Microsoft AI wants all its employees to be AI native by the end of the fiscal year, says VP of design Liz Danzico - Fortune
Finanzdaten der Microsoft Corporation-Aktie (MSFT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):